New Industrial Agreement Boosts Radiopharmaceutical Research
College of Arts and Science
The recently announced agreement between the University of Missouri Research Reactor (MURR®) and AAA, Advanced Accelerator Applications International, SA (AAA), a Novartis company, holds distinct significance for the College of Arts and Science.
Recently Carolyn Anderson, PhD, joined A&S’s Chemistry Department as the Simón-Ellebracht Chair in Medicinal Chemistry to lead a new center specifically designed to research and discover radiopharmaceutical cancer treatments. The Molecular Imaging and Theranostics Center (MITC) will be a hub for discovery of novel radiolabeled agents that can see and/or treat cancer.